When investors look at high-quality insurance names like Arch Capital (ACGL), RenRe (RNR), and W.R. Berkley (WRB),
they shouldn't expect to find big bargains very often. These companies
have all shown themselves to be quite adapt at pricing risk, allocating
capital, and maneuvering themselves into lines of business that can
maximize their returns, and the Street is typically happy to pay for
that quality and consistency.
While I don't expect to pick up W.R.
Berkley on the cheap, I'm worried that the valuation on this specialty
insurer has overshot the mark. Berkley's management may be right that
weak underwriting profitability across the sector will serve as a
tailwind for rate increases, but I'm concerned that the influx of
competition and capital into specialty insurance could create some
limits. At the same time, I'm a little nervous about company's reserves
and the large amount of leverage put to work here. W.R. Berkley has been
a top-notch performer for years and management deserves the benefit of
the doubt. Even so, I'm not going to pay up to this extent to own the
shares.
Please continue here:
It's Hard To See How W.R. Berkley Gets A Higher Multiple From Here
No comments:
Post a Comment